ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

ClinicalTrials.gov ID: NCT03654274

Public ClinicalTrials.gov record NCT03654274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SPIRIT EXTENSION: An International Phase 3 Open-Label, Single-Arm, Safety and Efficacy Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Endometriosis-Associated Pain

Study identification

NCT ID
NCT03654274
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Myovant Sciences GmbH
Industry
Enrollment
802 participants

Conditions and interventions

Conditions

Interventions

  • Estradiol/norethindrone acetate Drug
  • Relugolix Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 51 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 21, 2018
Primary completion
Dec 15, 2021
Completion
Jan 30, 2023
Last update posted
Aug 7, 2023

2018 – 2023

United States locations

U.S. sites
60
U.S. states
25
U.S. cities
53
Facility City State ZIP Site status
Andalusia Andalusia Alabama 36420
Scottsdale Scottsdale Arizona 85251
Tucson Tucson Arizona 85704
Tuscon Tucson Arizona 85712
Canoga Park Canoga Park California 91303
Los Angeles Los Angeles California 70433
San Diego San Diego California 92111
Greenwood Village Greenwood Village Colorado 80111
Washington Washington D.C. District of Columbia 20036
Aventura Aventura Florida 33180
Fort Myers Fort Myers Florida 33912
Hialeah Hialeah Florida 33012
Hialeah Hialeah Florida 33016
Margate Margate Florida 33063
Miami Miami Florida 33126
Miami Miami Florida 33155
Sarasota Sarasota Florida 34239
Tampa Tampa Florida 33606
Atlanta Atlanta Georgia 30312
Atlanta Atlanta Georgia 30363
Augusta Augusta Georgia 30909
Norcross Norcross Georgia 30093
Idaho Falls Idaho Falls Idaho 83404
Oakbrook Oakbrook Terrace Illinois 60523
Park Ridge Park Ridge Illinois 60068
Shawnee Shawnee Mission Kansas 66218
Marrero Marrero Louisiana 70072
Towson Towson Maryland 21204
Saginaw Saginaw Michigan 48602
Jefferson City Jefferson City Missouri 65109
St. Louis St Louis Missouri 63141
Omaha Omaha Nebraska 68130
Las Vegas Las Vegas Nevada 89113
Durham Durham North Carolina 27713
New Bern New Bern North Carolina 28562
Winston Salem Winston-Salem North Carolina 27103
Akron Akron Ohio 44313
Columbus Columbus Ohio 43235
Englewood Englewood Ohio 45322
Hershey Hershey Pennsylvania 17033-0850
Columbia Columbia South Carolina 29201
Chattanooga Chattanooga Tennessee 37404
Memphis Memphis Tennessee 38120
Beaumont Beaumont Texas 77702
Corpus Christi Corpus Christi Texas 78412
Dallas Dallas Texas 75231
Fort Worth Fort Worth Texas 76104
Houston Houston Texas 77030
Houston Houston Texas 77054
Irving Irving Texas 75062
San Antonio San Antonio Texas 78258
Sugar Land Sugar Land Texas 77479
Webster Webster Texas 77598
Salt Lake City Salt Lake City Utah 84102
Salt Lake City Salt Lake City Utah 84107
Salt Lake City Salt Lake City Utah 84124
Norfolk Norfolk Virginia 23507
Richmond Richmond Virginia 23235
Virginia Beach Virginia Beach Virginia 23502
Seattle Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03654274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03654274 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →